XML 120 R53.htm IDEA: XBRL DOCUMENT
v3.20.1

Acquisition of Prismic Pharmaceutical (Narrative) (Details) | 1 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 28, 2019 CAD ($) Share $ / shares shares | Dec. 31, 2019 CAD ($) shares | Dec. 31, 2018 CAD ($) shares
Disclosure of detailed information about business combination [line items] |  |  |
Shares issued |  | $ 11,539,417 | $ 47,853,745
Number of warrants issued | shares |  | 67,598 | 236,148
Prismic Pharmaceuticals Inc. ("Prismic") |  |  |
Disclosure of detailed information about business combination [line items] |  |  |
Consideration transferred, acquisition-date fair value | $ 20,887,209 |  |
Prismic Pharmaceuticals Inc. ("Prismic") | Class B subordinate voting shares |  |  |
Disclosure of detailed information about business combination [line items] |  |  |
Consideration transferred, acquisition-date fair value | $ 16,431,818 |  |
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc (shares) | shares | 510,940 |  |
Share issue price per share | $ / shares | $ 32.16 |  |
Prismic Pharmaceuticals Inc. ("Prismic") | Stock options |  |  |
Disclosure of detailed information about business combination [line items] |  |  |
Consideration transferred, acquisition-date fair value | $ 2,567,305 |  |
Number of instruments or interests issued or issuable | Share | 89,898 |  |
Prismic Pharmaceuticals Inc. ("Prismic") | Warrants |  |  |
Disclosure of detailed information about business combination [line items] |  |  |
Consideration transferred, acquisition-date fair value | $ 1,888,086 |  |
Number of instruments or interests issued or issuable | Share | 67,598 |  |

X
- Definition The increase (decrease) in equity shares resulting from acquisition of net assets. + References No definition available. + Details
Name: | huge_IncreaseDecreaseThroughAcquisitionOfNetAssetsShares
Namespace Prefix: | huge_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents number of warrants granted during period. + References No definition available. + Details
Name: | huge_NumberOfWarrantsGranted
Namespace Prefix: | huge_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the price per share of shares issued. + References No definition available. + Details
Name: | huge_ShareIssuePricePerShare
Namespace Prefix: | huge_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfBusinessCombinationsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_EquityInterestsOfAcquirer
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The increase in equity through the issue of equity instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 106 -Subparagraph d -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_106_d_iii&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_IssueOfEquity
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of instruments or interests issued or issuable at acquisition date for equity interests of the acquirer transferred as consideration in a business combination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph f -Clause iv -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_NumberOfInstrumentsOrInterestsIssuedOrIssuable
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | huge_LegalEntitiesAxis=huge_PrismicPharmaceuticalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=huge_ClassBVotingSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=huge_StockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=huge_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |